Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

GOOD HEALTH PRODUCTS ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Bankruptcy risk for industry   2.3% 2.3% 2.3% 2.3% 2.3% 2.3% 2.3% 2.3%   Bankruptcy risk   12.0% 8.2% 9.9% 6.3% 9.1% 8.4% 18.2% 18.0%   Credit score (0-100)   21 31 25 36 26 28 8 8   Credit rating   BB BB BB BBB BB BB B B   Credit limit (kDKK)   -0.0 -0.0 -0.0 -0.0 -0.0 -0.0 -0.0 -0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   567 587 603 633 372 335 0.0 0.0   EBITDA   124 223 241 337 150 168 0.0 0.0   EBIT   107 206 224 320 133 151 0.0 0.0   Pre-tax profit (PTP)   -74.6 26.9 53.1 132.5 -37.3 -24.6 0.0 0.0   Net earnings   -74.6 26.9 53.1 132.5 -37.3 -24.6 0.0 0.0   Pre-tax profit without non-rec. items   -74.6 26.9 53.1 133 -37.3 -24.6 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Tangible assets total   1,029 1,013 996 979 963 946 0.0 0.0   Shareholders equity total   -1,342 -1,315 -1,262 -1,129 -1,166 -1,191 -1,316 -1,316   Interest-bearing liabilities   2,373 2,301 2,141 2,016 2,060 2,082 1,316 1,316   Balance sheet total (assets)   1,130 1,105 1,110 1,180 1,053 1,039 0.0 0.0   Net Debt   2,342 2,286 2,099 1,890 2,038 2,063 1,316 1,316     See the entire balance sheet 1000.0 Volume  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   567 587 603 633 372 335 0.0 0.0   Gross profit growth   -14.8% 3.5% 2.8% 5.0% -41.2% -10.0% -100.0% 0.0%   Employees   2 2 2 2 2 2 0 0   Employee growth %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   1,130 1,105 1,110 1,180 1,053 1,039 0 0   Balance sheet change%   0.4% -2.2% 0.5% 6.2% -10.7% -1.3% -100.0% 0.0%   Added value   123.7 222.8 240.5 337.1 149.8 168.0 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   -33 -33 -33 -33 -33 -33 -946 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   2.0 3.0 4.0 5.0 5.0 5.0 0.0 0.0   1000.0 Profitability  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   18.9% 35.1% 37.1% 50.6% 35.8% 45.2% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   4.4% 8.4% 9.3% 13.7% 5.9% 6.8% 0.0% 0.0%   ROI %   4.6% 8.8% 10.1% 15.4% 6.5% 7.3% 0.0% 0.0%   ROE %   -6.6% 2.4% 4.8% 11.6% -3.3% -2.3% 0.0% 0.0%   1000.0 Solidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Equity ratio %   -54.3% -54.3% -53.2% -48.9% -52.6% -53.4% -100.0% -100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   1,893.9% 1,026.0% 872.6% 560.5% 1,360.7% 1,227.6% 0.0% 0.0%   Gearing %   -176.9% -175.0% -169.7% -178.5% -176.6% -174.8% -100.0% -100.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   7.8% 7.7% 7.7% 9.0% 8.4% 8.5% 0.0% 0.0%   1000.0 Liquidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Quick Ratio   0.2 0.2 0.2 0.4 0.2 0.1 0.0 0.0   Current Ratio   0.2 0.2 0.3 0.4 0.2 0.2 0.0 0.0   Cash and cash equivalent   31.1 15.5 42.8 126.0 22.0 19.7 0.0 0.0   1000.0 Capital use efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   -337.8 -348.3 -337.7 -252.3 -336.8 -396.5 -657.9 -657.9   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   62 111 120 169 75 84 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   62 111 120 169 75 84 0 0   EBIT / employee   54 103 112 160 67 76 0 0   Net earnings / employee   -37 13 27 66 -19 -12 0 0